19.10
-2.15
(-10.12%)
At close: January 10 at 4:00:02 PM EST
19.10
+0.00
+(0.00%)
After hours: January 10 at 5:41:12 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
COOK JENNIFER E Director | Sale | Jun 6, 2024 | 20,038 |
FLATLEY JAY T Director | Stock Award(Grant) | May 31, 2024 | 346,496 |
HO CAROLE Officer | Sale | Jan 7, 2025 | 383,892 |
KLEIN PETER S Director | Stock Award(Grant) | May 31, 2024 | 21,496 |
KROGNES STEVE E Director | Sale | Jan 7, 2025 | 807,554 |
SATO VICKI LEE Director | Sale | Jan 2, 2025 | 107,976 |
SCHENKEIN DAVID P Director | Conversion of Exercise of derivative security | Nov 11, 2024 | 66,684 |
SCHUTH ALEXANDER O Chief Operating Officer | Sale | Jan 7, 2025 | 768,057 |
TESSIER LAVIGNE MARC T Director | Stock Award(Grant) | May 31, 2024 | 2,117,410 |
WATTS RYAN J Chief Executive Officer | Sale | Jan 7, 2025 | 2,455,680 |
Related Tickers
STOK Stoke Therapeutics, Inc.
9.00
+0.45%
DYN Dyne Therapeutics, Inc.
15.87
-31.15%
JANX Janux Therapeutics, Inc.
46.76
-7.99%
CRNX Crinetics Pharmaceuticals, Inc.
40.59
-16.31%
APLS Apellis Pharmaceuticals, Inc.
27.44
-16.85%
VRNA Verona Pharma plc
45.20
-2.16%
SLRN Acelyrin, Inc.
2.0600
-3.74%
SRRK Scholar Rock Holding Corporation
40.49
-0.88%
APGE Apogee Therapeutics, Inc.
41.05
-16.58%
RARE Ultragenyx Pharmaceutical Inc.
42.07
-3.62%